Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cancer Therapy: Preclinical

C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and Carboplatin

Zhijian Gao, Xiaoyin Xu, Bruce McClane, Qing Zeng, Babak Litkouhi, William R. Welch, Ross S. Berkowitz, Samuel C. Mok and Elizabeth I.O. Garner
Zhijian Gao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoyin Xu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce McClane
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qing Zeng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Babak Litkouhi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William R. Welch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ross S. Berkowitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel C. Mok
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth I.O. Garner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-10-1644 Published March 2011
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: January 2011 to February 2021

AbstractFull-text HTMLPDF
Total395915821374

Cited By

Article Information

Volume 17, Issue 5, pp. 1065-1074

DOI 
https://doi.org/10.1158/1078-0432.CCR-10-1644
PubMed 
21123456

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Received June 21, 2010
  • Revision received November 17, 2010
  • Accepted November 18, 2010
  • Published first December 1, 2010.

Article Versions

  • Previous version (December 1, 2010 - 07:41).
  • Previous version (February 15, 2011 - 09:31).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2010 American Association for Cancer Research.

Author Information

  1. Zhijian Gao1,
  2. Xiaoyin Xu2,
  3. Bruce McClane3,
  4. Qing Zeng2,
  5. Babak Litkouhi1,
  6. William R. Welch4,
  7. Ross S. Berkowitz1,5,
  8. Samuel C. Mok6, and
  9. Elizabeth I.O. Garner1,5
  1. Authors' Affiliations: 1Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology and 2Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; 3Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; 4Department of Pathology, Brigham and Women's Hospital and 5Dana-Farber Harvard Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; and 6Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
  1. Corresponding Author:
    Zhijian Gao, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Phone: 617-525-9596; Fax: 617-278-6961. E-mail: zhijian_gao{at}yahoo.com
View Full Text
PreviousNext
Back to top
Clinical Cancer Research: 17 (5)
March 2011
Volume 17, Issue 5
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and Carboplatin
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and Carboplatin
Zhijian Gao, Xiaoyin Xu, Bruce McClane, Qing Zeng, Babak Litkouhi, William R. Welch, Ross S. Berkowitz, Samuel C. Mok and Elizabeth I.O. Garner
Clin Cancer Res March 1 2011 (17) (5) 1065-1074; DOI: 10.1158/1078-0432.CCR-10-1644

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
C Terminus of Clostridium perfringens Enterotoxin Downregulates CLDN4 and Sensitizes Ovarian Cancer Cells to Taxol and Carboplatin
Zhijian Gao, Xiaoyin Xu, Bruce McClane, Qing Zeng, Babak Litkouhi, William R. Welch, Ross S. Berkowitz, Samuel C. Mok and Elizabeth I.O. Garner
Clin Cancer Res March 1 2011 (17) (5) 1065-1074; DOI: 10.1158/1078-0432.CCR-10-1644
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Grant Support
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Enhanced Delivery of SN38-TOA NPs in NBs
  • Toxicity and Efficacy of a GADD34-encoding Oncolytic HSV
  • Survivin mAbs Inhibit Tumor Growth
Show more Cancer Therapy: Preclinical
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement